Please login to the form below

Not currently logged in
Email:
Password:

Celgene hires Thomas Moriarty to lead legal strategy

Joins as general counsel and corporate secretary from Medco Health Solutions

Thomas Moriarty has joined Celgene as general counsel and corporate secretary, a role that will see him  lead global legal strategy at the US biopharma and serve on its management committee.

“Tom Moriarty brings a wealth of experience in global strategic and legal healthcare management,” said Robert Hugin, chair and CEO of Celgene.

“His extensive legal background, as well as his significant leadership experience will provide new insight and valuable perspective on the increasingly complex global healthcare environment.”

This background includes 12 years at Medco Health Solutions from 2000 to 2012, during which he spent his final four years as general counsel and corporate secretary.

Moriarty held several other legal, regulatory, public policy and corporate governance positions at Medco including president, global pharmaceutical strategies; senior VP, pharma strategies and solutions; and senior VP of business development.

Prior to joining Medco, he served as assistant general counsel - pharma and North America for Merial Limited, a Merck & Co and Aventis Company, and as senior attorney for Merck.

9th May 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics